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Since the 70' s in twenties century, the rapid increase of the medical expenses and 
the control of such expenses have become the common problem of various countries，
including China.How can we enable our country to have a good Medical Insurance, but 
also does not cause the national financial burden to be overweight? The control of the 
medical expenses is one of most essential factors. Various countries' governments have 
conducted long-term and systemic research. Among them, because of the good expense 
control mechanism and the quality assurance mechanism, the US's HMO occupies the 
important status in the Medical Insurance market. 
At present, China is carrying on the Medical Insurance System Reform, but the 
question of expense control is also the key point of it. The establish of the effective 
expense control mechanism，the restriction mechanism of the medical service and the 
risk share mechanism, are the core contents of The Medical Insurance System Reform. 
How can we control the fast growth of the medical expenditure effectively under the 
premise that we can ensure the medical service's quality .It is without doubt the focal 
point of each reform measure. 
Because of the restriction of the Hygienic System, HMO can' t be widely carried 
out in our country. But its basic idea is worth thinking deeply and used for reference . 
This article analyzes the feasibility of the HMO's certain strategies and considers the 
effective control of the medical expense carried out in China.  
This article's frame is as follows:  
The first chapter, elaborates the background, the significance, the references, the 
research mentality and the deficiencies of this article. 
The second chapter, gives a simple introduction of the present situation of our 
country's Medical Insurance System Reform and the expense control practice. It has 
also constructs the consumer and the supplier model with various factors. Then it carries 
on the analysis of the importantance degree from the economic angle, including the key 
point of the expense control. Finally it has carried on the analysis of the Moral Hazard 
in the Medical Insurance in our country's reality performance. 
The third chapter, elaborates the HMO's strategies in the expense control and the 
quality assurance from the two angles(consumer and the supplier). Then it makes a  













medical expense control in our country. 
The fourth chapter, profiting from HMO the experience, has carried on the detailed 
elaboration of the expense control strategies in our country's Medical Insurance System 
Reform from the aspects of the insured and the medical organ. 
The fifth chapter is conclusion. Elaborateing the primary, the writing characteristic, 
the deficiencies as well as the research schedule of this article, which will continue to 
study from now on. 
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1978 110.21 32.2 47.4 20.4 3.04 11.5 
1980 143.23 36.2 42.6 21.2 3.17 14.5 
1985 279.00 38.6 33.0 28.5 3.11 26.4 
1990 747.36 25.1 39.2 35.7 4.03 65.4 
1995 2155.13 18.0 35.6 46.4 3.69 177.9 
1996 2709.42 17.0 32.3 50.6 3.99 221.4 
1997 3196.71 16.4 30.8 52.8 4.29 258.6 
1998 3678.72 16.0 29.1 54.8 4.70 294.9 
1999 4047.50 15.8 28.3 55.9 4.93 321.8 
2000 4586.63 15.5 25.5 59.0 5.13 361.9 
2001 5025.93 15.9 24.1 60.0 5.16 393.8 
2002 5790.03 15.7 26.6 57.7 5.51 450.7 
2003 6584.10 17.0 27.2 55.8 5.62 509.5 









































































































表 1-2：主要 OECD 国家卫生费用占 GDP 的比重 
 1960 1970 1980 1990 1995 2000 2002 2004 
澳大利亚 4 - 6.8 7.5 8 8.8 9.1 9.6 
加拿大 5.4 7 7.1 9 9.2 8.9 9.7 9.9 
法国 3.8 5.3 7 8.4 9.4 9.2 10 10.5 
日本 3 4.5 6.5 5.9 7.1 7.6 7.9 - 
英国 3.9 4.5 5.6 6 7 7.3 7.7 8.1 
美国 5.1 7 8.8 11.9 13.3 13.3 14.7 15.3 
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实践证明从医疗服务提供者着手是 有效率的一种方式，HMO 正是着重从供

















1.2  医疗费用控制的研究综述 
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兰德公司(Rand Corporation)所进行的医疗保险试验(Health Insurance Experiment，
HIE)。[4]HIE 选取美国六个地区的居民家庭加入五种不同的保险方案：看病完全免











免费 86.7 1019 100 
25%的费用负担 78.8 826 81 
50%的费用负担 74.3 764 85 
95%的费用负担 68.0 700 67 
个人起付线 72.6 817 80 
资料来源：Newhouse etal,1993, p.44. 
 







































按病种付费(Diagnosis-related Grouping，DRGs)是美国耶鲁大学的 Mills， 
Fetter，Riedel 及 Averill 共同研究提出的。即根据病例的特征以及资源耗费类型，
将病例分成 467 类，规定每一类病人及其疾病的治疗费率。[5] 
预付制(Prospective Payment System，PPS)是以 DRGs 为付费基准，对医院进
行预先补偿的支付方式。预付制 大的一个特点就是引入了费用控制的激励机制。
在预付制的激励下，医院会更多地考虑如何减少费用和提高效率问题，从而达到
费用控制的目的。美国以 DRGs 为基准的预付制改革，确实在 20 世纪 80 年代对
美国医疗保险的住院费用起到明显的抑制作用。因此，这项支付制度改革的成功
经验，也成为其他国家争相效法的对象。 
    （2）管理式医疗(Managed Care)及健康维持组织(HMO) 
在长期实践过程中，医疗费用控制措施的发展逐步从侧重需方控制向侧重供
方控制发展、从数量控制向结构控制发展、从限制性控制向引导性控制发展、从
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